Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors

This publication has 43 references indexed in Scilit:

• A Pilot Study ofIn VivoLiver-Directed Gene Transfer with an Adenoviral Vector in Partial Ornithine Transcarbamylase Deficiency
  Human Gene Therapy, 2002
• Activation of Innate Immunity in Nonhuman Primates Following Intraportal Administration of Adenoviral Vectors
  Molecular Therapy, 2001
• Adenovirus-Mediated Expression of Human Coagulation Factor IX in the Rhesus Macaque Is Associated With Dose-Limiting Toxicity
  Blood, 1999
• Adenoviral Gene Therapy Leads to Rapid Induction of Multiple Chemokines and Acute Neutrophil-Dependent Hepatic Injury in Vivo
  Human Gene Therapy, 1999
• Inhibition of Tumor Necrosis FactorαDecreases Inflammation and Prolongs Adenovirus Gene Expression in Lung and Liver
  Human Gene Therapy, 1998
• Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.
  Journal of Clinical Investigation, 1997
• Successful expression of human factor IX following repeat administration of adenoviral vector in mice.
  Proceedings of the National Academy of Sciences, 1996
• Gene Therapy for Hemophilia B: Host Immunosuppression Prolongs the Therapeutic Effect of Adenovirus-Mediated Factor IX Expression
  Human Gene Therapy, 1995
• Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis
  Nature Genetics, 1994
• Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
  Proceedings of the National Academy of Sciences, 1994